div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails5jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails6jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=7Page 7button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=7 data-page=7 class=ts-thumb lazyload alt=Page 7: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails7jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=8Page 8button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=8 data-page=8 class=ts-thumb lazyload alt=Page 8: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails8jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=9Page 9button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=9 data-page=9 class=ts-thumb lazyload alt=Page 9: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails9jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=10Page 10button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=10 data-page=10 class=ts-thumb lazyload alt=Page 10: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails10jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=11Page 11button div class=ts-imageimg data-url=1142015-the-pharma-business-model-has-long-called-that-valeant-uses-tohtmlpage=11 data-page=11 class=ts-thumb lazyload alt=Page 11: oversighthousegov · 1142015 · The pharma business model has long called that Valeant uses to mask its price increases and shift them to insurance companies Valeant loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader033vdocumentsusreader033viewer20220421135e8f5bdb9ec5bf2b2058e90ehtml5thumbnails11jpg width=140 height=200 divdiv
